ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $53,000 | -92.5% | 11,940 | -75.0% | 0.00% | -85.7% |
Q4 2021 | $703,000 | -29.7% | 47,821 | 0.0% | 0.01% | +75.0% |
Q3 2021 | $1,000,000 | -7.3% | 47,821 | -21.6% | 0.00% | -33.3% |
Q2 2021 | $1,079,000 | -42.8% | 60,976 | -20.8% | 0.01% | -40.0% |
Q1 2021 | $1,887,000 | -42.3% | 77,000 | -20.2% | 0.01% | -60.0% |
Q4 2020 | $3,268,000 | +69.7% | 96,536 | +25.4% | 0.02% | +8.7% |
Q3 2020 | $1,926,000 | -25.8% | 77,000 | 0.0% | 0.02% | -20.7% |
Q2 2020 | $2,597,000 | – | 77,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 4,768,181 | $116,820,000 | 11.19% |
Memorial Sloan Kettering Cancer Center | 602,272 | $14,756,000 | 9.10% |
Euclidean Capital LLC | 996,734 | $24,420,000 | 8.17% |
Invus Financial Advisors, LLC | 1,007,575 | $24,686,000 | 5.66% |
EcoR1 Capital, LLC | 3,092,218 | $75,759,000 | 3.36% |
Ally Bridge Group (NY) LLC | 413,061 | $10,120,000 | 1.94% |
EMERALD ADVISERS, LLC | 615,511 | $15,080,000 | 0.54% |
Orbimed Advisors | 2,337,574 | $57,271,000 | 0.54% |
EMERALD MUTUAL FUND ADVISERS TRUST | 624,210 | $15,293,000 | 0.51% |
Casdin Capital, LLC | 601,515 | $14,737,000 | 0.44% |